ArticleCancer medicine2019

Nonconserved miR-608 suppresses prostate cancer progression through RAC2/PAK4/LIMK1 and BCL2L1/caspase-3 pathways by targeting the 3'-UTRs of RAC2/BCL2L1 and the coding region of PAK4.

Xu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.